Your email has been added to our waiting list and we will send an invite to you as soon as possible. Thank you for your patience.
In the meantime, if you happen to run a blog, our newly launched Blog Enhancement Suite can utilize the immense power of community to help you get more audience, engagement, content, and revenue with your own embeddable community! It will breathe new life into your blog and can automate many of the tedious tasks that come with the territory, so you can focus more on what matters most... writing.
Help spread the word about Snapzu:
Let others know about Snapzu by tweeting about us. We appreciate every mention!
Drug with rage-inducing 5,000% price-hike now has $1/pill competitor
Turing Pharmaceuticals, the company that last month raised the price of the decades-old drug Daraprim from $13.50 a pill to $750, now has a competitor. Imprimis Pharmaceuticals, Inc., a specialty pharmaceutical company based in San Diego, announced today that it has made an alternative to Daraprim that costs about a buck a pill—or $99 for a 100-pill supply.